Identification of biomarkers and pathogenesis of lung cancer without targeted metabolomics based on uplc-q-tof /MS
Not Applicable
- Conditions
- ung cancer
- Registration Number
- ITMCTR1900002555
- Lead Sponsor
- The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. in line with the standard of diagnosis and treatment of common malignant tumors compiled by the medical department of the People's Republic of China,Patients with lung malignancy diagnosed by pathology or cytology;
2. the survival period was estimated to be more than 3 months. In general, Karnorfsy=30 points, ecog-ps <=4 points;
3. aged 18-80 years old;
4. stop radiation and chemotherapy > for 2 months;
5. patients are willing to accept the program, compliance.
Exclusion Criteria
1. does not meet the inclusion criteria;
2. pregnant or lactating women;
3. combined with serious cardiovascular and cerebrovascular diseases, or mental disorders and other diseases;
4. participate in other clinical trials;
5. Poor compliance.
Study & Design
- Study Type
- Basic Science
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method potential differential metabolites of lung cancer;
- Secondary Outcome Measures
Name Time Method